Health
Neanderthal-derived protein may reduce the severity of COVID-19 – Medical Xpress
Researchers at the Lady Davis Institute (LDI) at the Jewish General Hospital have discovered that increased levels of the protein OAS1 are associated with reduced…
Researchers at the Lady Davis Institute (LDI) at the Jewish General Hospital have discovered that increased levels of the protein OAS1 are associated with reduced mortality and less severe disease requiring ventilation among patients with COVID-19. Using drugs that boost OAS1 levels could be explored to try to improve these outcomes. The findings are published today in Nature Medicine.
“Our analysis shows evidence that OAS1 has a protective effect against COVID-19 susceptibility and severity,” explains…
-
General17 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat
-
Noosa News14 hours agoAlternative pathways to university explained
-
Noosa News20 hours agoTributes for woman allegedly mowed down on footpath in Maroochydore; Guilherme Dal Bo charged
-
General22 hours agoIncreased police powers begin at Adelaide Oval Ashes Test following Bondi attacks